A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
DRUG

Alivium®

400mg of Ibuprofen equivalent to 8mL (50mg/mL) oral suspension of the Reference Drug

DRUG

Ibuprofen

400mg of Ibuprofen equivalent to 10mL (40mg/mL) oral suspension of the Test Drug

Trial Locations (1)

CEP:74935-530

Pfizer Investigational Site, Aparecida de Goiânia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01466517 - A Relative BioavailabilityStudy Of Ibuprofen 40mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form. | Biotech Hunter | Biotech Hunter